Efficacy and Safety of LXI-15028 Comparing With Lansoprazole in the Treatment of Duodenal Ulcer
Clinical trial NCT05010954 · COMPLETED
Trial details
- NCT number
- NCT05010954
- Sponsor
- Shandong Luoxin Pharmaceutical Group Stock Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-18
- Primary completion
- 2022-09-28
- Enrollment
- 400
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.